Investigating ways to eliminate HIV for better health outcomes
STudy of Acute HIV for investiGating Eradication Strategies (STAGES)
['FUNDING_OTHER'] · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · NIH-11118300
This study is looking for ways to help people with HIV stay healthy without needing to take daily medication, by exploring how certain signals in the immune system can help reduce the virus in the body, and it invites patients to participate in trials to discover new treatment options.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF CALIFORNIA, SAN FRANCISCO (nih funded) |
| Locations | 1 site (SAN FRANCISCO, UNITED STATES) |
| Trial ID | NIH-11118300 on ClinicalTrials.gov |
What this research studies
This research focuses on finding methods to achieve long-term remission from HIV without the need for ongoing antiretroviral therapy (ART). It aims to understand how certain immune system signals, specifically class II cytokines, influence the decay of the HIV reservoir in the body. By studying different stages of HIV infection and treatment, the researchers hope to identify new therapeutic strategies that could lead to a cure. Patients may be involved in trials that explore these mechanisms and their effects on HIV control.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with acute HIV infection or those undergoing ART.
Not a fit: Patients with chronic HIV infection who are not currently undergoing treatment may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a cure for HIV, allowing patients to live without the need for lifelong medication.
How similar studies have performed: Previous research has shown promise in understanding the role of immune signals in HIV control, but this specific approach is novel and aims to fill critical gaps in current knowledge.
Where this research is happening
SAN FRANCISCO, UNITED STATES
- UNIVERSITY OF CALIFORNIA, SAN FRANCISCO — SAN FRANCISCO, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: LEE, SULGGI ANGELA — UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
- Study coordinator: LEE, SULGGI ANGELA
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Acquired Immune Deficiency Syndrome Virus, Acquired Immunodeficiency Syndrome Virus, Autoimmune Diseases